)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Gufic Biosciences (509079) investor relations material
Gufic Biosciences Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary17 Nov, 2025
Executive summary
Focused execution in hospital injectables, women's health, aesthetics, and surgical platforms, with strong emphasis on critical care, fertility, and toxin portfolios.
Achieved total revenue of ₹230.4 Cr in Q2 FY26, up from ₹204.2 Cr in Q2 FY25, and ₹457.3 Cr for H1 FY26, up from ₹407 Cr in H1 FY25.
Standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, were reviewed and approved by the Board and auditors, with no material misstatements identified.
Indore facility commenced production in Oct 2024, targeting global regulatory standards and margin accretion by FY27.
International business expanded with first EU marketing authorization and 24 new product/facility approvals across multiple regulated and emerging markets.
Financial highlights
Q2 FY26 revenue was INR 2,300 million, up from INR 2,270 million in Q1 and up 12.8% year-over-year; H1 FY26 revenue up 12.4% year-over-year.
EBITDA for Q2 FY26 was ₹37.9 Cr with a margin of 16.45%, compared to ₹38.7 Cr and 18.95% in Q2 FY25.
PAT for Q2 FY26 stood at ₹14.9 Cr, down from ₹21.8 Cr in Q2 FY25; H1 FY26 PAT was ₹27 Cr versus ₹42.6 Cr in H1 FY25.
Indore plant contributed all incremental revenue; Navsari capacity fully utilized.
Standalone net profit for Q2 FY26 was ₹1,493.71 lakhs, compared to ₹1,207.33 lakhs in Q2 FY25; consolidated net profit was ₹1,682.40 lakhs.
Outlook and guidance
Indore facility expected to reach EBITDA break-even by Q4 FY 2026 and margin-accretive from FY 2027.
CMO business anticipated to pick up from Q3, with more clients transitioning to Indore.
International business projected to grow 32-33% year-over-year, driven by new tenders and market entries.
Strategic focus on expanding regulated market presence, scaling CMO, and launching new products in critical care, fertility, and aesthetics.
The company expanded its international presence by investing in Gufic Ireland Limited during the quarter.
Indore EBITDA breakeven impact on margins?
Strategic growth focus beyond Indore scale-up?
Stunnox international expansion hurdles?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Gufic Biosciences earnings date
Q3 25/2616 Feb, 2026
Next Gufic Biosciences earnings date
Q3 25/2616 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Gufic Biosciences Limited is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and herbal products. The company specializes in injectables, lyophilized formulations, antifungals, antibiotics, and critical care medicines, catering to both domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage